Treatment of Uncomplicated Cellulitis with Cephalexin and Doxycycline
For uncomplicated cellulitis, cephalexin 500 mg orally 3-4 times daily for 5 days is the recommended first-line treatment, with doxycycline being an alternative option when MRSA coverage is needed. 1
First-Line Treatment for Uncomplicated Cellulitis
Cephalexin (Keflex)
- Dosage: 500 mg orally 3-4 times daily
- Duration: 5-6 days 1
- Target organisms: Primarily effective against Streptococcus pyogenes and methicillin-susceptible Staphylococcus aureus (MSSA) 2
- Indication: FDA-approved for skin and skin structure infections caused by Staphylococcus aureus and/or Streptococcus pyogenes 2
When to Consider Doxycycline
Doxycycline should be considered when MRSA coverage is needed, particularly in patients with:
- Prior MRSA infection
- Recent hospitalization
- Antibiotic use in the past 3 months
- Close contact with MRSA-infected individuals
- Penetrating trauma
- Evidence of MRSA infection elsewhere
- MRSA nasal colonization
- Injection drug use
- Systemic inflammatory response syndrome (SIRS) 1
Evidence Supporting Treatment Recommendations
Treatment Duration
- 5 days of antibiotic therapy is sufficient for uncomplicated cellulitis 1, 3
- A randomized controlled trial showed no significant difference in clinical outcomes between 5 days and 10 days of therapy (98% success rate in both groups) 3
- Treatment should be extended if the infection has not improved within 5 days 1
MRSA Coverage
- For nonpurulent cellulitis (without abscess or purulent drainage), beta-hemolytic streptococci are the predominant pathogens, and MRSA coverage is generally not necessary 4, 5
- A randomized controlled trial found that adding trimethoprim-sulfamethoxazole (TMP-SMX) to cephalexin did not significantly improve outcomes for uncomplicated cellulitis in the per-protocol analysis 6
- However, in areas with high MRSA prevalence, antibiotics with MRSA activity showed higher success rates compared to cephalexin alone 7
Treatment Algorithm for Uncomplicated Cellulitis
Initial Assessment:
- Determine if the cellulitis is purulent (with abscess or drainage) or nonpurulent
- Assess for MRSA risk factors
- Check for signs of systemic illness or severe infection
For Nonpurulent Cellulitis without MRSA Risk Factors:
- First choice: Cephalexin 500 mg orally 3-4 times daily for 5 days 1
For Nonpurulent Cellulitis with MRSA Risk Factors:
- Consider doxycycline as an alternative
- Or use cephalexin plus an MRSA-active agent if severe or extensive
For Purulent Cellulitis:
- MRSA coverage is recommended (doxycycline would be appropriate)
Follow-up Assessment:
- Evaluate response after 48-72 hours
- If not improving, consider:
- Extending treatment duration
- Changing antibiotics based on likely pathogens and local resistance patterns
- Assessing for complications or underlying conditions
Common Pitfalls and Caveats
- Inadequate treatment duration: While 5 days is typically sufficient, treatment should be extended if the infection has not improved 1
- Failure to address predisposing factors: Treat underlying conditions that may contribute to cellulitis 1
- Inappropriate MRSA coverage: Routine MRSA coverage is not necessary for all cases of nonpurulent cellulitis 4, 5
- Missing signs of deeper infection: Patients with SIRS, altered mental status, hemodynamic instability, or signs of deeper infection should be admitted for IV antibiotics 1
- Cross-reactivity concerns: Patients with immediate (anaphylactic-type) hypersensitivity to penicillin may have up to 10% cross-reactivity with cephalexin 1
Adjunctive Measures
- Elevation of the affected area to reduce edema
- Treatment of predisposing factors (edema, underlying skin disorders)
- Careful examination and treatment of interdigital toe spaces
- Maintaining good personal hygiene 1